Non Invasive Assessment Of Treatment For Common Type Of Breast Cancer

Non-invasive imaging can measure how well patients with the most common form of breast cancer - estrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual meeting May 29 - June 2, 2009, Orland, Fl.

More: continued here

Filed under: Breast Cancer on June 1st, 2009